Northrop Grumman Other Non-Current Liabilities decreased by 1.2% to $2.66B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $2.38B to $2.66B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 4.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.28B | $2.30B | $2.00B | $1.99B | $1.98B | $1.99B | $2.04B | $1.89B | $1.84B | $1.99B | $2.84B | $2.64B | $2.67B | $2.74B | $2.33B | $2.38B | $2.45B | $2.54B | $2.69B | $2.66B |
| QoQ Change | — | +0.8% | -13.2% | -0.3% | -0.8% | +0.6% | +2.6% | -7.2% | -3.0% | +8.2% | +42.9% | -7.0% | +1.2% | +2.6% | -15.1% | +2.1% | +2.9% | +3.6% | +6.2% | -1.2% |
| YoY Change | — | — | — | — | -13.5% | -13.6% | +2.1% | -4.9% | -7.0% | -0.1% | +39.2% | +39.5% | +45.6% | +38.1% | -17.9% | -9.9% | -8.5% | -7.6% | +15.5% | +11.8% |